Business

Organon launches Miudella IUD safety study enrollment
Pharmaceutical firm Organon initiates enrollment for a post-market safety program evaluating its Miudella intrauterine device.

Inderes Q2 2026 revenue up 14%, all units grow
Finnish financial services firm reports broad-based growth across all business segments for the quarter, with revenue increasing 14% year-over-year.

SPDI extends Adven loans to October, adds £100k commitment
Specialist lender extends financing facility for Adven Group by three months and increases total commitment by £100,000.

C4 beats earnings estimates by $0.03, revenue misses forecasts
The company reported adjusted earnings per share of $0.32, exceeding expectations, but revenue of $1.2 billion fell short of analyst projections.

Harvard Bioscience raises 2026 guidance after Q3 beat
Medical technology firm posts quarterly earnings above expectations and lifts full-year outlook for 2026, citing strong demand in life sciences tools.

Xtant Medical misses earnings estimates on revenue shortfall
Medical device maker Xtant Medical reported adjusted EPS of $0.01, below the $0.06 forecast, as revenue declined 11% year-over-year.

Ceragon beats earnings estimates by $0.01 per share
Quarterly profit and revenue exceed analyst forecasts as demand for wireless backhaul solutions strengthens.

908 Devices posts revenue beat, misses earnings by 17 cents
Life sciences firm 908 Devices reported adjusted earnings of 16 cents per share, below the 33-cent estimate, while revenue exceeded Wall Street forecasts.

Broadwind misses earnings, revenue forecasts by slim margins
Industrial components maker Broadwind reported adjusted EPS below estimates by $0.02, while revenue trailed analyst projections. Shares slipped in pre-market trading.

Broadwind shares drop 6% after Q2 revenue misses estimates
Wind tower and lattice structures manufacturer Broadwind reported second-quarter revenue below analyst expectations, sending shares down 6% in early trading.

Fennec Pharma shares jump 8% after Q2 revenue, earnings beat
Fennec Pharmaceuticals surged 8% in premarket trading after reporting second-quarter results that exceeded analyst expectations for revenue and earnings.

Eikon selects 0.60 mg/m² dose for melanoma trial
Biotech firm Eikon Pharmaceuticals finalizes dosing for Phase 2 melanoma study TeLuRide-006, targeting efficacy and safety.

Ryman Hospitality plans $700M notes for Orlando acquisition
Hospitality firm to issue senior notes to finance the purchase of a Florida resort, extending its portfolio in the Orlando market.

HUYA posts earnings miss, revenue below forecasts
Chinese live-streaming platform HUYA reported a per-share loss of ¥0.22, missing analyst expectations, while revenue declined year-over-year.

EVgo opens flagship charging station in Detroit area
The 350 kW fast-charging site adds 12 dispensers and 24 parking spots, supporting Detroit’s push to expand EV infrastructure.

Sea reports Q2 earnings miss, revenue beats forecasts
Digital entertainment and e-commerce giant Sea reported second-quarter earnings that fell short of expectations, though revenue exceeded market projections.

Grandstand debuts Rollcard debit card for sports betting customers
New debit card integrates directly with betting accounts, streamlining deposits and withdrawals for U.S. sports bettors.

DarioHealth posts profit beat, revenue misses forecasts
Digital health firm DarioHealth reported adjusted earnings per share of $0.40 above Wall Street estimates, though revenue fell short of analyst projections for the quarter.

Planet Green expands into lactoferrin sourcing and distribution
Specialty ingredients firm Planet Green enters lactoferrin market through new sourcing and distribution agreements. Deal marks expansion beyond core operations.

Cardinal Infrastructure posts Q2 revenue beat, lifts full-year forecast
The infrastructure specialist reported second-quarter revenue of $1.2 billion, topping Wall Street estimates, and raised its full-year outlook on sustained demand for data-center and energy projects.

Cardinal Health earnings top estimates, revenue misses forecast
Healthcare services provider posts adjusted EPS of $1.55, beating consensus by $0.19, while revenue of $51.2 billion fell short of Wall Street estimates.

Maria Shevchuk to keynote Platform Global conference in France
Ukrainian tech entrepreneur and investor Maria Shevchuk will deliver a keynote address at the Platform Global conference in Paris next month.

XTI Aerospace delays Q2 2026 earnings release
Company cites need for additional time to finalize financial statements; new date to be announced.

Eli Lilly to deploy Veeva Vault CRM globally
Pharmaceutical giant Eli Lilly selects Veeva Systems' cloud-based CRM platform to standardize commercial operations across international markets.

Americold expands direct-to-consumer fulfillment services
Move aims to capitalize on rising demand for cold storage logistics in e-commerce amid supply chain shifts.

